• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number ETBF3216C145E
Device Problem Inaccurate Delivery (2339)
Event Date 01/23/2014
Event Type  Injury  
Event Description
An endurant ii stent graft system was implanted for the endovascular treatment of an abdominal aortic aneurysm.The patient had a single right renal artery and two left renal arteries.It was reported that when deploying the stent graft the angio confirmed the stent graft was below the two left renal arteries which were the lowest.Upon completion of the final angiogram all renal arteries appeared patent.However after reviewing the angiogram it appeared one of the proximal stent graft markers was partially in the left renal artery.The physician decided to place two renal stents one in each of the two left renal arteries without incident.The cause of the occlusion was determined to be due to poor visualization as both left renal arteries were superimposed over each other.No additional clinical sequelae were reported and the patient is fine.
 
Manufacturer Narrative
(b)(4).Evaluation, results: inherent risk of procedure (vessel occlusion), caused by another drug/device (poor visualization); evaluation, conclusion: known inherent risk of a procedure (vessel occlusion), another device caused failure (poor visualization).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC CARDIOVASCULAR
3576 unocal place
santa rosa CA 95403
Manufacturer Contact
ludmila voulfson
3576 unocal place
santa rosa, CA 95403
7075661229
MDR Report Key3633006
MDR Text Key17949799
Report Number2953200-2014-00284
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/23/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/16/2015
Device Catalogue NumberETBF3216C145E
Device Lot NumberV04136406
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/23/2014
Initial Date FDA Received02/18/2014
Date Device Manufactured10/18/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00066 YR
-
-